FDA Approves THC Drug Syndros For Weight Loss in AIDS Patients
FDA Approves THC Drug Syndros
FDA Approves THC Drug Syndros To Treat anorexia associated with weight loss in AIDS patients. The drug is an orally administered liquid formula of the pharmaceutical cannabinoid dronabinol. Dronabinol is a pharmaceutical version of tetrahydrocannabinol or THC found in the cannabis plant.
The FDA approved Syndros for the treatment of anorexia associated with patients with weight loss due to AIDS, and treatment of chemotherapy patients with nausea and vomiting which did not respond to other antiemetic treatments. Syndros is still awaiting scheduling by the U.S. Drug Enforcement Administration.
- The Minnesota Medical Marijuana Program Almost at Full Strength.
- Seattle medical marijuana dispensaries without a recreational pot license shut down due to new law.
- Attorneys are asking whether Ohio’s new medical marijuana law that bars employers from disciplining professionals from working with marijuana businesses applies to them.